Showing results (341-350 of 515) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|January 12, 2024
Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1William J Sandborn, Bruce E Sands, Sharif Uddin, et al.
Crohn'S & Colitis 360|January 12, 2024
Diet and Nutrition in Inflammatory Bowel Disease: A Review of the LiteratureScott Manski, Nicholas Noverati, Tatiana Policarpo, et al.
Crohn'S & Colitis 360|January 8, 2024
The Comorbidity of Patient-Reported Crohn's Disease Activity and Depression: The Role of Health Behavior MediatorsLawrence S Gaines, Michael D Kappelman, David A Schwartz, et al.
Crohn'S & Colitis 360|March 28, 2024
Environmental Exposure to Trace Elements and Heavy Metals Preceding the Clinical Onset of Inflammatory Bowel DiseaseIago Rodríguez-Lago, José Luis Cabriada, Ainhoa Rodríguez, et al.
Crohn'S & Colitis 360|March 11, 2024
Perceptions Toward Established and Novel Dietary Therapies for Crohn's Disease Management Among Adult Patients: Results From a Questionnaire SurveyAleksandra Jatkowska, Bernadette White, Paige Jaskolski, et al.
Crohn'S & Colitis 360|September 30, 2024
Correction to: Spontaneous Loss-of-Function Dock2 Mutation Alters Murine Colitis Sensitivity and Is a Confounding Variable in Inflammatory Bowel Disease Research
Crohn'S & Colitis 360|March 1, 2024
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative ColitisDavid T Rubin, Joana Torres, Miguel Regueiro, et al.
Crohn'S & Colitis 360|November 6, 2023
Training Pearl: Welcome to the CC360 Fellow's CornerHilary K Michel, Lisa Malter
Crohn'S & Colitis 360|August 10, 2023
Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical PracticeJill K J Gaidos, Badr Al Bawardy, Francis A Farraye, et al.
Crohn'S & Colitis 360|August 28, 2023
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE StudiesWilliam J Sandborn, Jingjing Chen, Krisztina Kisfalvi, et al.
Pageof 52